Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Hepáticas y Digestivas (8)

2024

  1. Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)

    Hepatology, Vol. 79, Núm. 1, pp. 135-148

2022

  1. Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles

    Hepatology, Vol. 76, Núm. 4, pp. 1121-1134

2018

  1. Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts

    Hepatology Communications, Vol. 2, Núm. 7, pp. 807-820

2017

  1. Deregulated neddylation in liver fibrosis

    Hepatology, Vol. 65, Núm. 2, pp. 694-709

  2. Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis

    Gastroenterology, Vol. 152, Núm. 6, pp. 1449-1461.e7

2013

  1. Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease

    Hepatology, Vol. 57, Núm. 2, pp. 505-514

2012

  1. Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression

    Journal of Proteome Research, Vol. 11, Núm. 4, pp. 2521-2532

2010

  1. Non-alcoholic fatty liver disease proteomics

    Proteomics - Clinical Applications, Vol. 4, Núm. 4, pp. 362-371